Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention

Effective platelet inhibition is the main goal of the antiplatelet therapy recommended as a standard treatment in the secondary prevention of non-embolic ischemic stroke. Acetylsalicylic acid (aspirin) and clopidogrel are commonly used for this purpose worldwide. A low biological response to antipla...

Descripción completa

Detalles Bibliográficos
Autor principal: Wiśniewski, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827369/
https://www.ncbi.nlm.nih.gov/pubmed/33435185
http://dx.doi.org/10.3390/medicina57010059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827369/
https://www.ncbi.nlm.nih.gov/pubmed/33435185
http://dx.doi.org/10.3390/medicina57010059

Ejemplares similares